(Q36355720)

English

Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

R J North

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

R H Neubauer

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

J J Huang

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

R C Newton

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

S E Loveless

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 December 1988

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

168

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

2031-2043

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Self-regulation of procoagulant events on the endothelial cell surface

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Interleukin 1: an immunological perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

30 September 2017

Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

29 June 2018

Human interleukin 1 is a cytocidal factor for several tumor cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

29 June 2018

Models of adoptive T-cell-mediated regression of established tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2189148

22 September 2018

The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3143799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3143799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin 1

1 reference

https://pubmed.ncbi.nlm.nih.gov/3143799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3143799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subtherapeutic numbers of tumour-sensitized, L3T4+, Ly 1+2- T cells are needed for endotoxin to cause regression of an established immunogenic tumour

1 reference

https://pubmed.ncbi.nlm.nih.gov/3143799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/3143799

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.168.6.2031

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36355720&oldid=1977090690"